GM, Novo Nordisk, Moderna, Marvell, CrowdStrike

Ozempic maker Novo Nordisk prepared to enter India despite patent expiry, generic competition
Novo Nordisk’s GLP-1 drug Semaglutide, sold under brand names Ozempic and Wegovy, has been hailed as a miracle drug for ...
The Financial Express2h
Novo Nordisk to launch new therapies in blood and growth disorders after success in diabetes and obesity
Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their ...
USA Today12d
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...
Novo Nordisk Launches National "My Ozempic® Era" Campaign Celebrating Stories of Inspirational Ozempic® Patients
Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...
STAT12d
Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders
The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...
Novo Nordisk to sell Wegovy at discount for cash-paying US customers
Novo Nordisk said on Wednesday it would offer doses of its weight-loss drug Wegovy at a reduced cost of $499 per month for ...
Ozempic, Cetaphil Makers Brace for Impact From Trump Tariffs
The European makers of Ozempic for diabetes and Cetaphil for dry skin said they would feel an impact from President Donald ...
Newser on MSN4d
FDA Change on Ozempic to Shake Up the Market
The shortage of Ozempic and Wegovy has been declared over by the Food and Drug Administration, a change that suggests higher ...